These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36859618)

  • 1. Evaluation of thresholding methods for the quantification of [
    Kim M; Seifert R; Fragemann J; Kersting D; Murray J; Jonske F; Pomykala KL; Egger J; Fendler WP; Herrmann K; Kleesiek J
    Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2196-2209. PubMed ID: 36859618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early molecular imaging response assessment based on determination of total viable tumor burden in [
    Rosar F; Wenner F; Khreish F; Dewes S; Wagenpfeil G; Hoffmann MA; Schreckenberger M; Bartholomä M; Ezziddin S
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1584-1594. PubMed ID: 34725725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative
    Kuo PH; Morris MJ; Hesterman J; Kendi AT; Rahbar K; Wei XX; Fang B; Adra N; Garje R; Michalski JM; Chi K; de Bono J; Fizazi K; Krause B; Sartor O; Tagawa ST; Ghebremariam S; Brackman M; Wong CC; Catafau AM; Benson T; Armstrong AJ; Herrmann K
    Radiology; 2024 Aug; 312(2):e233460. PubMed ID: 39162634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSMA-PET follow-up to assess response in patients not receiving PSMA therapy: Is there value beyond localization of disease?
    Küper AT; Kersting D; Telli T; Herrmann K; Rominger A; Afshar-Oromieh A; Lopes L; Karkampouna S; Shi K; Kim M; Hadaschik B; Darr C; Umutlu L; Fendler WP; Seifert R
    Theranostics; 2024; 14(9):3623-3633. PubMed ID: 38948055
    [No Abstract]   [Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-treatment
    Eisazadeh R; Mirshahvalad SA; Schwieghofer-Zwink G; Hehenwarter L; Rendl G; Gampenrieder S; Greil R; Pirich C; Beheshti M
    Mol Imaging Biol; 2024 Apr; 26(2):360-369. PubMed ID: 38360991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the Relationship and Prognostic Significance of Cell-Free DNA Levels and the PSMA-Positive Tumor Volume in Men with Prostate Cancer: A Retrospective-Prospective [
    Kluge K; Einspieler H; Haberl D; Spielvogel C; Stoiber S; Vraka C; Papp L; Wunsch S; Egger G; Kramer G; Grubmüller B; Shariat S; Hacker M; Kenner L; Haug A
    J Nucl Med; 2024 Jan; 65(1):63-70. PubMed ID: 38050125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. qPSMA: Semiautomatic Software for Whole-Body Tumor Burden Assessment in Prostate Cancer Using
    Gafita A; Bieth M; Krönke M; Tetteh G; Navarro F; Wang H; Günther E; Menze B; Weber WA; Eiber M
    J Nucl Med; 2019 Sep; 60(9):1277-1283. PubMed ID: 30850484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of quantitative whole body PET parameters on [
    Ayati N; McIntosh L; Buteau J; Alipour R; Pudis M; Daw N; Jackson P; Hofman MS
    Cancer Imaging; 2024 May; 24(1):57. PubMed ID: 38711135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of whole-body tumour burden on [68Ga]PSMA-11 PET/CT for response assessment of [177Lu]PSMA-617 radioligand therapy: a retrospective analysis of serum PSA level and imaging derived parameters before and after two cycles of therapy.
    Michalski K; Mix M; Meyer PT; Ruf J
    Nuklearmedizin; 2019 Dec; 58(6):443-450. PubMed ID: 31724145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiautomatically Quantified Tumor Volume Using
    Seifert R; Herrmann K; Kleesiek J; Schäfers M; Shah V; Xu Z; Chabin G; Grbic S; Spottiswoode B; Rahbar K
    J Nucl Med; 2020 Dec; 61(12):1786-1792. PubMed ID: 32332147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi-automatic evaluation of baseline whole-body tumor burden as an imaging biomarker of
    Zou Q; Jiao J; Zou MH; Li MZ; Yang T; Xu L; Zhang Y
    Abdom Radiol (NY); 2020 Dec; 45(12):4202-4213. PubMed ID: 32948911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between whole body volumetric parameters of
    Yildirim ÖA; Gündoğan C; Can C; Poyraz K; Erdur E; Kömek H
    Ann Nucl Med; 2021 May; 35(5):540-548. PubMed ID: 33586097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors of tumor sink effect: Insights from
    Tuncel M; Telli T; Tuncalı MÇ; Karabulut E
    Ann Nucl Med; 2021 May; 35(5):529-539. PubMed ID: 33586096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial Experience with Volumetric
    Schmuck S; von Klot CA; Henkenberens C; Sohns JM; Christiansen H; Wester HJ; Ross TL; Bengel FM; Derlin T
    J Nucl Med; 2017 Dec; 58(12):1962-1968. PubMed ID: 28522740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [
    Peters SMB; Hofferber R; Privé BM; de Bakker M; Gotthardt M; Janssen M; de Lange F; Muselaers CHJ; Mehra N; Witjes JA; Costa PF; Nagarajah J; Konijnenberg MW; Jentzen W
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1101-1112. PubMed ID: 34623453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Tumor Volume Assessment on PSMA PET After
    Kind F; Eder AC; Jilg CA; Hartrampf PE; Meyer PT; Ruf J; Michalski K
    J Nucl Med; 2023 Apr; 64(4):605-610. PubMed ID: 36302658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of baseline
    Telli TA; Ozguven S; Alan O; Filizoglu N; Ozturk MA; Sariyar N; Isik S; Arikan R; Demircan NC; Basoglu T; Cetin IA; Ones T; Ercelep O; Dane F; Yumuk PF
    Ann Nucl Med; 2022 Nov; 36(11):964-975. PubMed ID: 35997890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [
    Seifert R; Kessel K; Schlack K; Weber M; Herrmann K; Spanke M; Fendler WP; Hadaschik B; Kleesiek J; Schäfers M; Weckesser M; Boegemann M; Rahbar K
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1200-1210. PubMed ID: 32970216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Translation and First In-Human Use of [
    Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
    Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.